MAP2K5 and malignant colon neoplasm: Taken together, these results indicate that ERK5 inhibition sensitizes colon cancer cells to 5-FU, at least in part, by inducing p53-dependent apoptosis, providing a functional mechanism connecting the MEK5/ERK5 cascade with 5-FU anticancer activity.